Please assess the completion status of the following clinical trial:

Trial Title: Trigen InterTAN vs Sliding Hip Screw RCT

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: SINGLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* has closed trochanteric hip fracture (AO/OTA 31-A1 or A2) requiring treatment with internal fixation~* has injury due to low energy trauma~* is independently ambulatory in living environment prior to injury (walking aids permitted)~* is \>60 years of age~* is willing and able to participate in required follow-up visits at the investigational site and to complete study procedures and questionnaires~* has consented to participate in the study by signing the Ethics Committee (EC) approved ICF~* has definitive fracture fixation \<72h from admission~Exclusion Criteria:~* has any additional injury or disability affecting mobility or affecting use of walking aids~* has a pathological fracture (excluding osteoporotic fracture)~* has an existing implant in study hip~* has diagnosis of an immunosuppressive disorder~* has an active infection, treated or untreated, systemic or at the site of the - has a condition that may interfere with the outcome of the study, including but not limited to: Paget's disease, Charcot's disease, vascular insufficiency, muscular atrophy, uncontrolled diabetes, renal insufficiency or neuromuscular disease~* has a BMI \>40~* has an inadequate bone stock to support the device which would make the procedure unjustifiable, including but not limited to: severe osteopenia/osteoporosis or family history of severe osteoporosis/osteopenia~* is pregnant or plans to become pregnant during the course of the study~* is a prisoner or is facing impending incarceration~* in the opinion of the PI, has an emotional or neurological condition that would interfere with their ability or willingness to participate in the study including mental illness, mental retardation, and drug or alcohol abuse~* is entered in another investigational drug, biologic, or device study or has been treated with an investigational product in the past 30 days~* is known to be at risk for lost to follow-up, or failure to return for scheduled visits

- Gender: ALL
- Minimum Age: 60 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Trigen Intertan (Type: OTHER): * Unique integrated interlocking screw and trapezoidal nail shape~* Resistance to femoral head rotation and cut-out~* Active compression through linear motion without rotation~* Single subtrochanteric lag screw option for stable fractures below lesser trochanter~* Preloaded cannulated set screw converts construct to fixed angle device~* Small proximal diameter of the nail promotes preservation of the lateral wall of the greater trochanter and gluteus medius tendon~* Clothespin tip for stress modulation in femoral shaft~* Potential for improved patient mobility and recovery~Manufactured by Smith \& Nephew Inc., 1450 Brooks Road, Memphis, TN 38116, U.S.A.~Interventions:~Randomisation to either Trigen Intertan or Sliding Hip Screw, Post-Surgery Follow Up
- Sliding Hip Screw (Type: OTHER): SHS is a generic term for a group of devices used for internal fixation of trochanteric hip fractures. Also known as Compression Hip Screw or Dynamic Hip Screw. All devices feature a lag screw inserted into the femoral neck and a side plate held in place by cortical screws inserted into the proximal femoral shaft.~Therapeutic effect is achieved by guided collapse, where the lag screw can slide in the barrel of the side plate which compresses the fracture as the patient begins to weight-bear.~Participating sites may use whichever brand of SHS is currently in use.~Interventions:~Randomisation to either Trigen Intertan or Sliding Hip Screw, Post-Surgery Follow Up

Based on this trial design, predict the completion outcome and termination type (if applicable).